About 17 Trademarks found for “VYD*”

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post-intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), huntington's disease, lewy body dementia, frontotemporal dementia, vascular dementia, parkinson's disease, cognitive impairment of aging, progressive multiple sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, cancer pain, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy induced neuropathy and other medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in als, pseudobulbar affect, levodopa-induced dyskinesias in parkinson's disease, agitation in ad, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine-adjuvant for genetic epilepsy due to nmda receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, post traumatic stress disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, obsessive compulsive disorder (OCD), hoarding, trichotillomania, eating disorders, generalized anxiety disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, attention deficit disorder (ADD), pervasive developmental disorders (PDD), asperger's syndrome, autism, menopausal hot flashes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, monotherapy and adjunctive use.

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post-intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), huntington's disease, lewy body dementia, frontotemporal dementia, vascular dementia, parkinson's disease, cognitive impairment of aging, progressive multiple sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, cancer pain, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy induced neuropathy and other medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in als, pseudobulbar affect, levodopa-induced dyskinesias in parkinson's disease, agitation in ad, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine-adjuvant for genetic epilepsy due to nmda receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, post traumatic stress disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, obsessive compulsive disorder (OCD), hoarding, trichotillomania, eating disorders, generalized anxiety disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, attention deficit disorder (ADD), pervasive developmental disorders (PDD), asperger's syndrome, autism, menopausal hot flashes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, monotherapy and adjunctive use.

Vaccines for the prevention of COVID-19.

Pre-recorded compact discs featuring music; pre-recorded DVDs featuring music and music videos; musical sound recordings; downloadable musical sound recordings

Clothing, namely, t-shirts, sweat shirts, shirts, pants, shorts, dresses, tights, tops, namely, tank tops, yoga tops, underwear, swimsuits, bikinis; footwear, namely, shoes, boots, sandals, casual footwear, men's, women's and children's footwear; headwear, namely, hats, caps, tuques, headbands

Pharmaceutical preparations for the treatment of a rare protein misfolding disease, namely, amyloidosis.

Chemical products used in agriculture, horticulture and forestry; manures and fertilizers; substrates for use as growing media without soil, namely substrates for growing and cultivating plants, crops and other vegetable life; finished hydrophilic polyurethane foam in the form of slabs, blocks, strips, rods, pipes and flakes; hydrophilic polyurethane foams also for use as media for growing and cultivating plants, crops and other vegetable life; non-metallic building materials, namely green roof materials, namely moisture retention and drainage structures composed of root barrier sheets, water retention and drainage boards, drainage mats, and filter cloth, for use for building green roofs, green walls and vertical gardens, for grassing roofs and cultivating roof gardens; non-metallic building materials, namely for controlling, managing and drainage of moisture and water on roofs, namely moisture retention and drainage structures composed of modular trays, featuring a growing medium and vegetation.

Finished hydrophilic polyurethane foam in the form of slabs, blocks, strips and flakes; non-metallic building materials, namely green roof materials, namely moisture retention and drainage structures composed of root barrier sheets, water retention and drainage boards, drainage mats, and filter cloth, for use for building green roofs, green walls and vertical gardens, for grassing roofs and cultivating roof gardens.

Pharmaceutical preparations for the treatment of dermatological diseases, disorders and conditions.

Chemicals for chromatography, namely, packing material for chromatography columns.

Chromatogrophy columns.

Synthetic resins for use as a plastic molding compound; synthetic resins for use in plastic extrusion and/or molding; nylon resins for use in the extrusion of synthetic fibers and synthetic profiles, and case and blown plastic films; synthetic and plastic resins; polymer resins used in the manufacture of resin unprocessed or fiber composites; unprocessed nylon resins; unprocessed plastic resins principally of nylon; synthetic and plastic resins for use in the manufacture of molding compounds; synthetic and plastic resins for use in the manufacture of carpet and textile fibers, automotive parts and home and commercial appliances; composite resins principally of nylon for use in the manufacture of molding compounds, carpet and textile fibers, automotive parts and home and commercial appliances; synthetic resins principally of nylon for use in plastic extrusion and molding; ignition resistant and heat stabilized synthetic plastic resins principally of nylon, also containing mineral reinforcement for use in the manufacture of molding compounds, carpet and textile fibers, automotive parts and home and commercial appliances; nylon resins for use in the manufacture of extrusion of synthetic fibers and synthetic profiles, and cast and blown plastic films.

Gutta percha, elastic rubber, balata and substitutes, articles made from these substances; plastics in the form of sheets, blocks, powders, granules, pastes, solutions and rods, being for use in manufactures, materials for packing, stopping or insulating; semi-processed resins in the form of powder, bars, blocks, pellets, rods, sheets and tubes, and extruded forms, all for use in further manufacture; semi-processed synthetic resins in the form of powder, bars, blocks, pellets, rods, sheets and tubes, for general industrial use; synthetic resinous polymers for use in the general industrial arts being semi finished products; semiprocessed plastics in the form of sheets, blocks and rods, being for use in further manufacture in the general industrial arts; synthetic resinous polymers for use in the general industrial arts (semi finished products).

Synthetic and plastic resins; resins principally of nylon; resins principally synthetic polymers mixed with reinforcing fiberglass; synthetic resins for use as a plastic molding compound; synthetic resins for use in plastic extrusion and molding; ignition resistant and heat stabilized synthetic plastic resins principally of nylon, also containing mineral reinforcement; nylon resins for use in the extrusion of synthetic fibers and synthetic profiles, and cast and blown plastic films; resins in the form of powder, bars, blocks, pellets, rods, sheets and tubes, and extruded forms for use in further manufacture; resins in the form of powder, bars, blocks, pellets, rods, sheets, and tubes, for general industrial use; synthetic resinous polymers for use in the general industrial arts being semi finished products, plastics in the form of sheets, blocks and rods, being for use in manufacture.